Efficacy and clinical cross-resistance of a new combination...

Efficacy and clinical cross-resistance of a new combination therapy (AMSA/VP16) in previously treated patients with acute nonlymphocytic leukemia.

Tschopp, L, von Fliedner, V E, Sauter, C, Maurice, P, Gratwohl, A, Fopp, M, Cavalli, F
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
4
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.1986.4.3.318
Date:
March, 1986
File:
PDF, 522 KB
1986
Conversion to is in progress
Conversion to is failed